Global Drug Repurposing Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 09, 2020 | 213 PAGES | REPORT CODE: CMM331141

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.

The Drug Repurposing is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The research provides insights for the global Drug Repurposing market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Drug Repurposing industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Drug Repurposing Market Segmentations:

By Players:

Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii

By Types:

Oncology
CNS Diseases
Neurodegenerative Diseases
Others

By End-User:

Hospitals
Ambulatory Surgical Centers
Others

By Regions:

North America

United States
Canada
Mexico

Europe

Germany
UK
France
Italy
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
Spain
Belgium
Poland
Russia
Turkey
Others

Asia-Pacific

China
Japan
India
South Korea
Australia and New Zealand
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
Brazil
Nigeria
South Africa
Argentina
Others

Table of Contents

1 Report Overview

1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Drug Repurposing Market
1.3 Market Segmentation by Type

1.3.1 Global Drug Repurposing Market Size and Growth Rate of Oncology from 2014 to 2026
1.3.2 Global Drug Repurposing Market Size and Growth Rate of CNS Diseases from 2014 to 2026
1.3.3 Global Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases from 2014 to 2026
1.3.4 Global Drug Repurposing Market Size and Growth Rate of Others from 2014 to 2026

1.4 Market Segmentation by End-Users

1.4.1 Global Drug Repurposing Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Global Drug Repurposing Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
1.4.3 Global Drug Repurposing Market Size and Growth Rate of Others from 2014 to 2026

1.5 Market Segmentation by Regions

1.5.1 North America Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.1.1 United States Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.1.2 Canada Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.1.3 Mexico Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.2 Europe Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.2.1 Germany Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.2 UK Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.3 France Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.4 Italy Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.5 Nordic Countries Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.6 Spain Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.7 Belgium Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.8 Poland Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.9 Russia Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.2.10 Turkey Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.3 Asia-Pacific Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.3.1 China Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.3.2 Japan Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.3.3 Australia and New Zealand Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.3.4 India Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.3.5 ASEAN Countries Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.3.6 South Korea Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.4 Latin America, Middle East & Africa Drug Repurposing Market Size and Growth Rate from 2014 to 2026

1.5.4.1 GCC Countries Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.4.2 Brazil Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.4.3 Nigeria Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.4.4 South Africa Drug Repurposing Market Size and Growth Rate from 2014 to 2026
1.5.4.5 Argentina Drug Repurposing Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

2.1 Market Trends and Dynamics

2.1.1 Market Challenges and Restraints
2.1.2 Market Opportunities and Potentials
2.1.3 Mergers and Acquisitions

2.2 Competitive Landscape Analysis

2.2.1 Industrial Concentration Analysis
2.2.2 Porter's Five Forces Analysis of the Industry
2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Drug Repurposing Market by Types

3.1 Product Development Trends of Different Types
3.2 Commercial Product Types of Major Vendors
3.3 Competitive Landscape Analysis of Different Types
3.4 Market Size of Drug Repurposing by Major Types

3.4.1 Drug Repurposing Market Size and Growth Rate of Oncology
3.4.2 Drug Repurposing Market Size and Growth Rate of CNS Diseases
3.4.3 Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases
3.4.4 Drug Repurposing Market Size and Growth Rate of Others

4 Segmentation of Drug Repurposing Market by End-Users

4.1 Downstream Client Analysis by End-Users
4.2 Competitive Landscape Analysis of Different End-Users
4.3 Market Potential Analysis of Different End-Users
4.4 Market Size of Drug Repurposing by Major End-Users

4.4.1 Market Size and Growth Rate of Drug Repurposing in Hospitals
4.4.2 Market Size and Growth Rate of Drug Repurposing in Ambulatory Surgical Centers
4.4.3 Market Size and Growth Rate of Drug Repurposing in Others

5 Market Analysis by Major Regions

5.1 Global Drug Repurposing Production Analysis by Major Regions
5.2 Global Drug Repurposing Consumption Analysis by Major Regions
5.3 Global Drug Repurposing Production, Import, Consumption and Export Analysis by Regions

5.3.1 North America Drug Repurposing Production, Import, Consumption and Export Analysis
5.3.2 Europe Drug Repurposing Production, Import, Consumption and Export Analysis
5.3.3 Asia Pacific Drug Repurposing Production, Import, Consumption and Export Analysis
5.3.4 Latin America, Middle East & Africa Drug Repurposing Production, Import, Consumption and Export Analysis

6 Product Commodity of Drug Repurposing Market in Major Countries

6.1 Top 5 Export Countries in Drug Repurposing market from 2014 to 2019

6.1.1 Top 5 Export Countries' Export Value Analysis in Drug Repurposing market from 2014 to 2019
6.1.2 Top 5 Export Countries' Export Volume Analysis in Drug Repurposing market from 2014 to 2019

6.2 Top 5 Import Countries in Drug Repurposing market from 2014 to 2019

6.2.1 Top 5 Import Countries' Import Value Analysis in Drug Repurposing market from 2014 to 2019
6.2.2 Top 5 Import Countries' Import Volume Analysis in Drug Repurposing market from 2014 to 2019

6.3 Emerging Top 3 Export Countries Analysis
6.4 Emerging Top 3 Import Countries Analysis

7 North America Drug Repurposing Landscape Analysis

7.1 North America Drug Repurposing Landscape Analysis by Major Types
7.2 North America Drug Repurposing Landscape Analysis by Major End-Users
7.3 North America Drug Repurposing Landscape Analysis by Major Countries

7.3.1 United States Drug Repurposing Market Volume and Growth Rate
7.3.2 Canada Drug Repurposing Market Volume and Growth Rate
7.3.3 Mexico Drug Repurposing Market Volume and Growth Rate

8 Europe Drug Repurposing Landscape Analysis

8.1 Europe Drug Repurposing Landscape Analysis by Major Types
8.2 Europe Drug Repurposing Landscape Analysis by Major End-Users
8.3 Europe Drug Repurposing Landscape Analysis by Major Countries

8.3.1 Germany Drug Repurposing Market Volume and Growth Rate
8.3.2 UK Drug Repurposing Market Volume and Growth Rate
8.3.3 France Drug Repurposing Market Volume and Growth Rate
8.3.4 Italy Drug Repurposing Market Volume and Growth Rate
8.3.5 Nordic Countries Drug Repurposing Market Volume and Growth Rate
8.3.6 Spain Drug Repurposing Market Volume and Growth Rate
8.3.7 Belgium Drug Repurposing Market Volume and Growth Rate
8.3.8 Poland Drug Repurposing Market Volume and Growth Rate
8.3.9 Russia Drug Repurposing Market Volume and Growth Rate
8.3.10 Turkey Drug Repurposing Market Volume and Growth Rate

9 Asia Pacific Drug Repurposing Landscape Analysis

9.1 Asia Pacific Drug Repurposing Landscape Analysis by Major Types
9.2 Asia Pacific Drug Repurposing Landscape Analysis by Major End-Users
9.3 Asia Pacific Drug Repurposing Landscape Analysis by Major Countries

9.3.1 China Drug Repurposing Market Volume and Growth Rate
9.3.2 Japan Drug Repurposing Market Volume and Growth Rate
9.3.3 Australia and New Zealand Drug Repurposing Market Volume and Growth Rate
9.3.4 India Drug Repurposing Market Volume and Growth Rate
9.3.5 ASEAN Countries Drug Repurposing Market Volume and Growth Rate
9.3.6 South Korea Drug Repurposing Market Volume and Growth Rate

10 Latin America, Middle East & Africa Drug Repurposing Landscape Analysis

10.1 Latin America, Middle East & Africa Drug Repurposing Landscape Analysis by Major Types
10.2 Latin America, Middle East & Africa Drug Repurposing Landscape Analysis by Major End-Users
10.3 Latin America, Middle East & Africa Drug Repurposing Landscape Analysis by Major Countries

10.3.1 GCC Countries Drug Repurposing Market Volume and Growth Rate
10.3.2 Brazil Drug Repurposing Market Volume and Growth Rate
10.3.3 Nigeria Drug Repurposing Market Volume and Growth Rate
10.3.4 South Africa Drug Repurposing Market Volume and Growth Rate
10.3.5 Argentina Drug Repurposing Market Volume and Growth Rate

11 Major Players Profile

11.1 Astellas Pharma

11.1.1 Astellas Pharma Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction

11.2 Biovista

11.2.1 Biovista Company Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction

11.3 Novartis

11.3.1 Novartis Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction

11.4 AbbVie

11.4.1 AbbVie Company Profile and Recent Development
11.4.2 Market Performance
11.4.3 Product and Service Introduction

11.5 Pfizer

11.5.1 Pfizer Company Profile and Recent Development
11.5.2 Market Performance
11.5.3 Product and Service Introduction

11.6 Allergan

11.6.1 Allergan Company Profile and Recent Development
11.6.2 Market Performance
11.6.3 Product and Service Introduction

11.7 NuMedii

11.7.1 NuMedii Company Profile and Recent Development
11.7.2 Market Performance
11.7.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 84 Figures and 199 Tables)

Figure Product Picture
Figure Drug Repurposing Market Size and Growth Rate of Oncology from 2014 to 2026
Figure Drug Repurposing Market Size and Growth Rate of CNS Diseases from 2014 to 2026
Figure Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases from 2014 to 2026
Figure Drug Repurposing Market Size and Growth Rate of Others from 2014 to 2026
Figure Market Share by Type in 2014
Figure Market Share by Type in 2018
Figure Market Share by Type in 2026
Figure Global Drug Repurposing Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Global Drug Repurposing Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
Figure Global Drug Repurposing Market Size and Growth Rate of Others from 2014 to 2026
Figure Market Share by End-User in 2014
Figure Market Share by End-User in 2018
Figure Market Share by End-User in 2026
Figure North America Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure United States Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Canada Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Mexico Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Europe Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Germany Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure UK Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure France Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Italy Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nordic Countries Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Spain Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Belgium Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Poland Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Russia Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Turkey Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Asia-Pacific Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure China Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Japan Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Australia and New Zealand Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure India Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure ASEAN Countries Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Korea Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure GCC Countries Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Brazil Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nigeria Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Africa Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Argentina Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026
Figure Development Trends and Industry Dynamics of Drug Repurposing Industry
Figure Market Challenges and Restraints
Figure Market Opportunities and Potentials
Table Mergers and Acquisition
Figure Market Share of TOP 3 Players in 2018
Figure Market Share of TOP 5 Players in 2018
Figure Market Share of TOP 6 Players from 2014 to 2019
Figure Porter's Five Forces Analysis
Figure New Entrant SWOT Analysis
Table Specifications of Different Types of Drug Repurposing
Figure Development Trends of Different Types
Table Commercial Products Types of Major Vendors
Figure Competitive Landscape Analysis of Different Types
Table Consumption of Drug Repurposing by Different Types from 2014 to 2026
Table Consumption Share of Drug Repurposing by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Oncology
Figure Market Size and Growth Rate of CNS Diseases
Figure Market Size and Growth Rate of Neurodegenerative Diseases
Figure Market Size and Growth Rate of Others
Table Downstream Client Analysis by End-Users
Figure Competitive Landscape Analysis of Different End-Users
Table Market Potential Analysis of Different End-Users
Table Consumption of Drug Repurposing by Different End-Users from 2014 to 2026
Table Consumption Share of Drug Repurposing by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Hospitals
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
Figure Market Size and Growth Rate of Others
Table Global Drug Repurposing Production by Major Regions
Table Global Drug Repurposing Production Share by Major Regions
Figure Global Drug Repurposing Production Share by Major Regions in 2014
Figure Global Drug Repurposing Production Share by Major Regions in 2018
Figure Global Drug Repurposing Production Share by Major Regions in 2026
Table Global Drug Repurposing Consumption by Major Regions
Table Global Drug Repurposing Consumption Share by Major Regions
Figure Global Drug Repurposing Consumption Share by Major Regions in 2014
Figure Global Drug Repurposing Consumption Share by Major Regions in 2018
Figure Global Drug Repurposing Consumption Share by Major Regions in 2026
Table North America Drug Repurposing Production, Import, Consumption and Export Analysis
Table Europe Drug Repurposing Production, Import, Consumption and Export Analysis
Table Asia Pacific Drug Repurposing Production, Import, Consumption and Export Analysis
Table Latin America, Middle East & Africa Drug Repurposing Production, Import, Consumption and Export Analysis
Table Top 5 Export Countries' Export Value Analysis in Drug Repurposing market from 2014 to 2019
Table Top 5 Export Countries' Export Volume Analysis in Drug Repurposing market from 2014 to 2019
Table Top 5 Import Countries' Import Value Analysis in Drug Repurposing market from 2014 to 2019
Table Top 5 Import Countries' Import Volume Analysis in Drug Repurposing market from 2014 to 2019
Figure Emerging Top 3 Export Countries Analysis
Figure Emerging Top 3 Import Countries Analysis
Table North America Drug Repurposing Consumption by Types from 2014 to 2026
Table North America Drug Repurposing Consumption Share by Types from 2014 to 2026
Figure North America Drug Repurposing Consumption Share by Types in 2014
Figure North America Drug Repurposing Consumption Share by Types in 2018
Figure North America Drug Repurposing Consumption Share by Types in 2026
Table North America Drug Repurposing Consumption by End-Users from 2014 to 2026
Table North America Drug Repurposing Consumption Share by End-Users from 2014 to 2026
Figure North America Drug Repurposing Consumption Share by End-Users in 2014
Figure North America Drug Repurposing Consumption Share by End-Users in 2018
Figure North America Drug Repurposing Consumption Share by End-Users in 2026
Table North America Drug Repurposing Consumption by Major Countries from 2014 to 2026
Table North America Drug Repurposing Consumption Share by Major Countries from 2014 to 2026
Figure North America Drug Repurposing Consumption Share by Major Countries in 2014
Figure North America Drug Repurposing Consumption Share by Major Countries in 2018
Figure North America Drug Repurposing Consumption Share by Major Countries in 2026
Figure United States Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Canada Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Mexico Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Table Europe Drug Repurposing Consumption by Types from 2014 to 2026
Table Europe Drug Repurposing Consumption Share by Types from 2014 to 2026
Figure Europe Drug Repurposing Consumption Share by Types in 2014
Figure Europe Drug Repurposing Consumption Share by Types in 2018
Figure Europe Drug Repurposing Consumption Share by Types in 2026
Table Europe Drug Repurposing Consumption by End-Users from 2014 to 2026
Table Europe Drug Repurposing Consumption Share by End-Users from 2014 to 2026
Figure Europe Drug Repurposing Consumption Share by End-Users in 2014
Figure Europe Drug Repurposing Consumption Share by End-Users in 2018
Figure Europe Drug Repurposing Consumption Share by End-Users in 2026
Table Europe Drug Repurposing Consumption by Major Countries from 2014 to 2026
Table Europe Drug Repurposing Consumption Share by Major Countries from 2014 to 2026
Figure Europe Drug Repurposing Consumption Share by Major Countries in 2014
Figure Europe Drug Repurposing Consumption Share by Major Countries in 2018
Figure Europe Drug Repurposing Consumption Share by Major Countries in 2026
Figure Germany Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure UK Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure France Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Italy Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Nordic Countries Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Belgium Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Poland Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Russia Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Turkey Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Table Asia Pacific Drug Repurposing Consumption by Types from 2014 to 2026
Table Asia Pacific Drug Repurposing Consumption Share by Types from 2014 to 2026
Figure Asia Pacific Drug Repurposing Consumption Share by Types in 2014
Figure Asia Pacific Drug Repurposing Consumption Share by Types in 2018
Figure Asia Pacific Drug Repurposing Consumption Share by Types in 2026
Table Asia Pacific Drug Repurposing Consumption by End-Users from 2014 to 2026
Table Asia Pacific Drug Repurposing Consumption Share by End-Users from 2014 to 2026
Figure Asia Pacific Drug Repurposing Consumption Share by End-Users in 2014
Figure Asia Pacific Drug Repurposing Consumption Share by End-Users in 2018
Figure Asia Pacific Drug Repurposing Consumption Share by End-Users in 2026
Table Asia Pacific Drug Repurposing Consumption by Major Countries from 2014 to 2026
Table Asia Pacific Drug Repurposing Consumption Share by Major Countries from 2014 to 2026
Figure Asia Pacific Drug Repurposing Consumption Share by Major Countries in 2014
Figure Asia Pacific Drug Repurposing Consumption Share by Major Countries in 2018
Figure Asia Pacific Drug Repurposing Consumption Share by Major Countries in 2026
Figure China Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Japan Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Australia and New ZealandDrug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure India Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure ASEAN Countries Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure South Korea Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Table Latin America, Middle East & Africa Drug Repurposing Consumption by Types from 2014 to 2026
Table Latin America, Middle East & Africa Drug Repurposing Consumption Share by Types from 2014 to 2026
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by Types in 2014
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by Types in 2018
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by Types in 2026
Table Latin America, Middle East & Africa Drug Repurposing Consumption by End-Users from 2014 to 2026
Table Latin America, Middle East & Africa Drug Repurposing Consumption Share by End-Users from 2014 to 2026
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by End-Users in 2014
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by End-Users in 2018
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by End-Users in 2026
Table Latin America, Middle East & Africa Drug Repurposing Consumption by Major Countries from 2014 to 2026
Table Latin America, Middle East & Africa Drug Repurposing Consumption Share by Major Countries from 2014 to 2026
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by Major Countries in 2014
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by Major Countries in 2018
Figure Latin America, Middle East & Africa Drug Repurposing Consumption Share by Major Countries in 2026
Figure GCC Countries Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Brazil Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Nigeria Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure South Africa Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Figure Argentina Drug Repurposing Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Astellas Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
Figure Sales and Growth Rate Analysis of Astellas Pharma
Figure Revenue and Market Share Analysis of Astellas Pharma
Table Product and Service Introduction of Astellas Pharma
Table Company Profile and Development Status of Biovista
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biovista
Figure Sales and Growth Rate Analysis of Biovista
Figure Revenue and Market Share Analysis of Biovista
Table Product and Service Introduction of Biovista
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Allergan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
Figure Sales and Growth Rate Analysis of Allergan
Figure Revenue and Market Share Analysis of Allergan
Table Product and Service Introduction of Allergan
Table Company Profile and Development Status of NuMedii
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuMedii
Figure Sales and Growth Rate Analysis of NuMedii
Figure Revenue and Market Share Analysis of NuMedii
Table Product and Service Introduction of NuMedii

REPORTS

Let’s Pullulate and Expand Your Business